Fenfluramine for stubborn infantile spasms
Part of Brain & nervous system clinical trials.
This Phase 2 trial studies fenfluramine to treat infantile spasms that haven’t improved after standard medicines (ACTH and vigabatrin). If you/your child has ongoing seizures, the study may offer another treatment option and will monitor safety closely, especially heart-related side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is 12 to 36 months old (inclusive).
- Your child has a clinical diagnosis of infantile spasms.
- Seizures are still happening despite adequate ACTH and vigabatrin treatment.
- Your child does not have significant preexisting heart or blood vessel disease.
- Your child has not used any cannabis/cannabinoid products in the last 14 days.
- Your child has not changed or started other second-line seizure treatments in the last 14 days (and no new dose changes).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a high-dose steroid (prednisolone) to vigabatrin works better than vigabatrin alone for infants with infantile spasms. It may help reduce seizures and improve early development, but your child’s prior treatments and health conditions must fit the study rules.
This study looks at brain recordings (video EEG) from babies and children who have had infantile spasms. It uses a computer program to better understand those spasms, which may help doctors diagnose and treat them more effectively.
This trial tests whether a longer course of steroids can keep infantile spasms from returning in babies who have already responded to standard treatment. It may help reduce the chance of relapse.
This trial tests the safety of a medicine called fenfluramine for children under 2 years old with Dravet syndrome. It aims to see if fenfluramine can help control seizures in very young children.
This study tests whether fenfluramine, a medication already used for seizures, can help people with Rett syndrome. It aims to see if it improves daily life and reduces symptoms.
This trial compares two types of brain stimulation—deep brain stimulation (DBS) and vagus nerve stimulation (VNS)—to see which works better for epileptic spasms in children with drug-resistant epilepsy. If your child has not responded to two or more seizure medicines, this study might help find a new way to control their spasms.
Hear when a new Infantile Spasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.